T Cell‐Independent Role of PD‐L1 in Kidney Repair: Mitigation of Tubular DNA Damage via PD‐L1/BRCA1 Interaction Following AKI
Open Access
- 27 April 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (40) , e75428
Abstract
Acute kidney injury (AKI) occurs in the patients undergoing anti‐programmed cell death protein 1‐ligand 1 (PD‐L1) therapy, indicating that PD‐L1 may play a critical role in maintaining renal homeostasis. However, the precise role and mechanism of PD‐L1 in AKI remains largely elusive. In this study, we found that PD‐L1 was primarily expressed in proximal tubules and significantly upregulated in both murine models of AKI and renal biopsy samples from AKI patients. Genetic specific deletion of PD‐L1 in mouse tubular epithelial cells (TECs) exacerbated renal injury in ischemia‐reperfusion injury‐induced AKI. Mechanistically, PD‐L1 was found to interact with BRCA1 and increase BRCA1 expression to safeguard TECs against DNA damage, thereby promoting cellular proliferation and suppressing apoptosis. To translate these findings into a potential therapeutic strategy, we developed a CGA‐functionalized extracellular vesicle delivery system for targeted delivery of PD‐L1 to injured TECs. This system efficiently restored PD‐L1 expression and alleviated DNA damage of TECs in both TEC‐specific PD‐L1 knockdown and T‐cell knockout AKI mouse models. Collectively, these findings uncover a novel function of PD‐L1 in promoting adaptive TEC repair through BRCA1 interaction, independent of its canonical immunomodulatory function of T cells, and suggest that PD‐L1 supplementation may represent a promising therapeutic strategy for AKI.Keywords
Funding Information
- National Natural Science Foundation of China (82070735)
- National Natural Science Foundation of China (82230022)
- National Natural Science Foundation of China (82030024)
- National Natural Science Foundation of China (81720108007)
- National Natural Science Foundation of China (82200772)
- Natural Science Foundation of Jiangsu Province (BK20251135)
- Natural Science Foundation of Jiangsu Province (BK20220828)
This publication has 47 references indexed in Scilit:
- Hydroxychloroquine alleviates renal fibrosis by modulating dendritic cells glycolipid metabolism and its crosstalk with renal tubular epithelial cellsEuropean Journal of Pharmacology, 2026
- PD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapyCell Reports, 2024
- Renal tubular epithelial cells response to injury in acute kidney injuryEBioMedicine, 2024
- Identification of a Novel ECM Remodeling Macrophage Subset in AKI to CKD Transition by Integrative Spatial and Single‐Cell AnalysisAdvanced Science, 2024
- Deubiquitinase BAP1 regulates stability of BRCA1 protein and inactivates the NF-κB signaling to protect mice from sepsis-induced acute kidney injuryChemico-Biological Interactions, 2023
- Extracellular vesicles for renal therapeutics: State of the art and future perspectiveJournal of Controlled Release, 2022
- The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancerPharmacology & Therapeutics, 2022
- NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune EvasionCell Metabolism, 2021
- Immune Checkpoint Inhibitors and Immune-Related Adverse Renal EventsKidney International Reports, 2020
- PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or ChemotherapyMolecular Cell, 2019